Benjamin Lockshin

898 total citations
13 papers, 614 citations indexed

About

Benjamin Lockshin is a scholar working on Immunology, Rheumatology and Economics and Econometrics. According to data from OpenAlex, Benjamin Lockshin has authored 13 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 4 papers in Rheumatology and 4 papers in Economics and Econometrics. Recurrent topics in Benjamin Lockshin's work include Psoriasis: Treatment and Pathogenesis (12 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Spondyloarthritis Studies and Treatments (3 papers). Benjamin Lockshin is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (12 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Spondyloarthritis Studies and Treatments (3 papers). Benjamin Lockshin collaborates with scholars based in United States and United Kingdom. Benjamin Lockshin's co-authors include Joseph F. Merola, Elinor Mody, Nehal N. Mehta, Heather Teague, Martin P. Playford, Amit K. Dey, Justin Rodante, Marcus Y. Chen, David A. Bluemke and Andrew Keel and has published in prestigious journals such as Circulation, Annals of the Rheumatic Diseases and Cardiovascular Research.

In The Last Decade

Benjamin Lockshin

12 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Lockshin United States 8 419 205 130 122 89 13 614
Oded Kimhi Israel 7 202 0.5× 379 1.8× 65 0.5× 52 0.4× 34 0.4× 10 530
Giorgia Grosso Sweden 9 205 0.5× 139 0.7× 34 0.3× 59 0.5× 19 0.2× 19 330
Violeta Bojincă Romania 13 146 0.3× 219 1.1× 25 0.2× 31 0.3× 46 0.5× 64 426
Tor Magne Madland Norway 11 171 0.4× 415 2.0× 40 0.3× 16 0.1× 62 0.7× 15 574
Rachel Gorodkin United Kingdom 10 104 0.2× 196 1.0× 45 0.3× 16 0.1× 33 0.4× 15 414
Milena Aksentijevich United States 4 151 0.4× 51 0.2× 110 0.8× 24 0.2× 70 0.8× 5 311
Bojana Stamenković Serbia 11 110 0.3× 166 0.8× 15 0.1× 50 0.4× 31 0.3× 41 449
Amy Wasserman United States 8 78 0.2× 177 0.9× 42 0.3× 24 0.2× 22 0.2× 15 327
A. L. Parke United States 8 94 0.2× 156 0.8× 38 0.3× 21 0.2× 69 0.8× 15 394
Cristina Costa Duarte Lanna Brazil 14 156 0.4× 301 1.5× 37 0.3× 13 0.1× 27 0.3× 33 466

Countries citing papers authored by Benjamin Lockshin

Since Specialization
Citations

This map shows the geographic impact of Benjamin Lockshin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Lockshin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Lockshin more than expected).

Fields of papers citing papers by Benjamin Lockshin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Lockshin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Lockshin. The network helps show where Benjamin Lockshin may publish in the future.

Co-authorship network of co-authors of Benjamin Lockshin

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Lockshin. A scholar is included among the top collaborators of Benjamin Lockshin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Lockshin. Benjamin Lockshin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lockshin, Benjamin, Ryan W. Harrison, Robert R. McLean, et al.. (2022). Outcomes in Ixekizumab Patients Following Exposure to Secukinumab and Other Biologics in the CorEvitas Psoriasis Registry. Dermatology and Therapy. 12(12). 2797–2815. 6 indexed citations
2.
Blauvelt, Andrew, Russel Burge, Gaia Gallo, et al.. (2022). A Retrospective Cohort Analysis of Treatment Patterns Over 1 Year in Patients with Psoriasis Treated with Ixekizumab or Guselkumab. Dermatology and Therapy. 12(3). 701–714. 11 indexed citations
3.
Lockshin, Benjamin, Angel M. Cronin, Ryan W. Harrison, et al.. (2021). Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: The Corrona Psoriasis Registry. Dermatologic Therapy. 34(2). e14808–e14808. 30 indexed citations
4.
Merola, Joseph F., Lourdes M. Pérez-Chada, Michael Siegel, et al.. (2020). The National Psoriasis Foundation psoriasis treatment targets in real‐world patients: prevalence and association with patient‐reported outcomes in the Corrona Psoriasis Registry. Journal of the European Academy of Dermatology and Venereology. 34(9). 2051–2058. 6 indexed citations
5.
Marchetti, Albert, et al.. (2020). Therapies for Psoriasis: Clinical and Economic Comparisons. Journal of Drugs in Dermatology. 19(11). 1101–1108.
6.
Mease, Phillip J., Evan Siegel, Heather Richmond, et al.. (2019). Impact of Clinical Specialty Setting and Geographic Regions on Disease Management in Patients with Psoriatic Arthritis in the United States: A Multicenter Observational Study. American Journal of Clinical Dermatology. 20(6). 873–880. 7 indexed citations
7.
Strober, Bruce, et al.. (2019). Apremilast mechanism of efficacy in systemic-naive patients with moderate plaque psoriasis: Pharmacodynamic results from the UNVEIL study. Journal of Dermatological Science. 96(3). 126–133. 15 indexed citations
8.
Elnabawi, Youssef, Evangelos K. Oikonomou, Amit K. Dey, et al.. (2019). Association of Biologic Therapy With Coronary Inflammation in Patients With Psoriasis as Assessed by Perivascular Fat Attenuation Index. JAMA Cardiology. 4(9). 885–885. 164 indexed citations
9.
Elnabawi, Youssef, Amit K. Dey, Aditya Goyal, et al.. (2019). Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study. Cardiovascular Research. 115(4). 721–728. 187 indexed citations
11.
Merola, Joseph F., Benjamin Lockshin, & Elinor Mody. (2017). Switching biologics in the treatment of psoriatic arthritis. Seminars in Arthritis and Rheumatism. 47(1). 29–37. 78 indexed citations
12.
Lerman, Joseph B, Aditya A. Joshi, Abhishek Chaturvedi, et al.. (2017). Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study. Circulation. 136(3). 263–276. 106 indexed citations
13.
Mitkov, Mario, Yevgeniy Balagula, & Benjamin Lockshin. (2014). Circumscribed plantar hypokeratosis. International Journal of Dermatology. 54(6). e203–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026